Legal Representation
Attorney
Tiffany D. Gehrke
USPTO Deadlines
Next Deadline
164 days remaining
NOA E-Mailed - SOU Required
Due Date
June 09, 2026
Extension Available
Until December 09, 2026
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 9, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 14, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 14, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 8, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 17, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 17, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 17, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 17, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 17, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 4, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 4, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 4, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 19, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Aug 19, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| May 19, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 19, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 19, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 6, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 4, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 3, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 3, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 3, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Nov 8, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of genetic diseases; Pharmaceutical products for cell therapy to treat genetic diseases
Class 040
Custom manufacture of biomedical compounds comprised of nucleotide polymers and biomedical compounds comprised of ribonucleic acid polymers all for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders for others
Class 042
Pharmaceutical research and development; Pharmaceutical research and development in the fields of gene therapies, gene editing, drug discovery and development; Pharmaceutical research and development incorporating artificial intelligence; Pharmaceutical research and development incorporating genetic learning; Scientific and industrial research in the field of gene therapies, RNA editing, drug discovery and development incorporating genetic learning; Scientific and industrial research incorporating artificial intelligence in the field of gene therapies, RNA editing, drug discovery and development incorporating genetic learning; Scientific and industrial research in the field of gene therapies, gene editing, drug discovery and development incorporating genetic learning; Medical and scientific research in the field of pharmaceuticals, genetics, gene editing, and genetic diseases
Additional Information
Design Mark
The mark consists of a stylized "O" design.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
040
042